drugset / Trial / NCT00515034

A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia

NCT00515034

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety and tolerability of doripenem compared to imipenem in Ventilator-assisted pneumonia and complicated Intra-abdominal Infection. The study population will include hospitalized patients (or patients resident in a chronic health care facility) who have a diagnosis of either Ventilator associated pneumonia or complicated Intra-abdominal Infection.

Timeline

Start
2007-10
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cilastatin Small molecule Intravenous
Subject Doripenem Small molecule 1 g Intravenous
Comparator IMIPENEM ANHYDROUS Small molecule Intravenous